|
|
||||||||
Ann Thorac Surg 1999;68:1144-1149
© 1999 The Society of Thoracic Surgeons
a Department of Thoracic Surgery and Endoscopy, Ruhrlandklinik, West German Cancer Center, University of Essen Medical School, Essen, Germany
b Cancer Research, Department of Internal Medicine, West German Cancer Center, University of Essen Medical School, Essen, Germany
c Department of Radiation Therapy, West German Cancer Center, University of Essen Medical School, Essen, Germany
Address reprint requests to Dr Stamatis, Ruhrlandklinik, Tüschener Weg 40, 45239 Essen-Heidhausen, Germany
e-mail: arbeitsgem.-Thoraxchirurgie{at}t.online
Presented at the Thirty-fifth Annual Meeting of The Society of Thoracic Surgeons, San Antonio, TX, Jan 2527, 1999.
Background. Preoperative chemoradiotherapy is feasible for selected patients with non-small cell lung cancer stage IIIb. The aim of this investigation was to analyze long-term results after this multimodality approach and to identify subgroups with improved long-term prognosis.
Methods. From March 1991 to June 1996, 56 patients were entered. Three cycles of cisplatin (P) (60 mg/m2, days 1 + 7) and etoposide (E) (150 mg/m2, days 3 to 5 qd 22) were followed by one cycle of radiotherapy/chemotherapy (RTx/CTx) (45 Gy, 1.5 Gy bid/3 weeks with P 50 mg/m2 days 2 + 9/E 100 mg/m2 days 4 to 6) followed by repeat mediastinoscopy and surgery.
Results. There were 46 men and 10 women (age 34 to 69 years, median 55 years; World Health Organization status 0 to 2, median 1). Twenty-eight had T4, and 32 had proven N3, in detail: T4N0/1, 10; T4N2, 14; T3N3, 9; T4N3, 4; and T1/2N3, 19. Thirty-four (61%) were operated on; 27 (48%) were completely (R0) resected. Survival at 5 years is 26% for all, and 43% for R0 patients. Toxicity included two deaths (one septicemia, one anastomosis insufficiency).
Conclusions. This intensive program proved to be highly effective in unfavorable IIIB subgroups with promising long-term survival for T4 tumors as well as N3 disease.
This article has been cited by other articles:
![]() |
V. Steger, T. Walles, B. Kosan, T. Walker, T. Kyriss, S. Veit, J. Dippon, and G. Friedel Trimodal Therapy for Histologically Proven N2/3 Non-Small Cell Lung Cancer: Mid-Term Results and Indicators for Survival. Ann. Thorac. Surg., June 1, 2009; 87(6): 1676 - 1683. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Kandioler, G. Stamatis, W. Eberhardt, S. Kappel, S. Zochbauer-Muller, I. Kuhrer, M. Mittlbock, R. Zwrtek, C. Aigner, C. Bichler, et al. Growing clinical evidence for the interaction of the p53 genotype and response to induction chemotherapy in advanced non-small cell lung cancer. J. Thorac. Cardiovasc. Surg., May 1, 2008; 135(5): 1036 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Garrido, J. L. Gonzalez-Larriba, A. Insa, M. Provencio, A. Torres, D. Isla, J. M. Sanchez, F. Cardenal, M. Domine, J. R. Barcelo, et al. Long-Term Survival Associated With Complete Resection After Induction Chemotherapy in Stage IIIA (N2) and IIIB (T4N0-1) Non Small-Cell Lung Cancer Patients: The Spanish Lung Cancer Group Trial 9901 J. Clin. Oncol., October 20, 2007; 25(30): 4736 - 4742. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marra, W. Eberhardt, C. Pottgen, D. Theegarten, S. Korfee, T. Gauler, M. Stuschke, and G. Stamatis Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour Eur. Respir. J., January 1, 2007; 29(1): 117 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. De Leyn, T. Lerut, and J. Vansteenkiste In Reply J. Clin. Oncol., November 20, 2006; 24(33): 5339 - 5340. [Full Text] [PDF] |
||||
![]() |
K. Ohno, T. Utsumi, Y. Sasaki, and Y. Suzuki Videopericardioscopy Using Endothoracic Sonography for Lung Cancer Staging Ann. Thorac. Surg., May 1, 2005; 79(5): 1780 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Semik, D. Riesenbeck, A. Linder, C. Schmid, P. Hoffknecht, A. Heinecke, H. H. Scheld, M. Thomas, and for The German Lung Cancer Cooperative Group Preoperative chemotherapy with and without additional radiochemotherapy: benefit and risk for surgery of stage III non-small cell lung cancer Eur. J. Cardiothorac. Surg., December 1, 2004; 26(6): 1205 - 1210. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. B. Ratto, R. Costa, G. Vassallo, A. Alloisio, P. Maineri, and P. Bruzzi Twelve-year experience with left atrial resection in the treatment of non-small cell lung cancer Ann. Thorac. Surg., July 1, 2004; 78(1): 234 - 237. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Cesario, S. Margaritora, D. Galetta, V. Porziella, P. Granone, R. M. D'Angelillo, L. Trodella, V. Cardaci, S. Sterzi, and P. Russo Correspondence re L. J. Wirth et al., Induction Docetaxel and Carboplatin Followed by Weekly Docetaxel and Carboplatin with Concurrent Radiotherapy, Then Surgery in Stage III Non-Small Cell Lung Cancer: a Phase I Study. Clin Cancer Res 2003;9:1698-704. Clin. Cancer Res., April 15, 2004; 10(8): 2902 - 2903. [Full Text] [PDF] |
||||
![]() |
K. Ohno, T. Utsumi, Y. Sasaki, and Y. Suzuki Re-evaluation of non-palpable scalene lymph node biopsy for the staging of non-small cell lung cancer Eur. J. Cardiothorac. Surg., April 1, 2004; 25(4): 492 - 496. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Galetta, A. Cesario, S. Margaritora, V. Porziella, G. Macis, R. M. D'Angelillo, L. Trodella, S. Sterzi, and P. Granone Enduring challenge in the treatment of nonsmall cell lung cancer with clinical stage IIIB: results of a trimodality approach Ann. Thorac. Surg., December 1, 2003; 76(6): 1802 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ichinose, Y. Fukuyama, H. Asoh, C. Ushijima, T. Okamoto, J. Ikeda, J. Okamoto, and M. Sakai Induction chemoradiotherapy and surgical resection for selected stage IIIB non-small-cell lung cancer Ann. Thorac. Surg., December 1, 2003; 76(6): 1810 - 1814. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C.M. Pitz, A. B. de la Riviere, H. A. van Swieten, C. J.J. Westermann, J.-W. J. Lammers, and J. M.M. van den Bosch Results of surgical treatment of T4 non-small cell lung cancer Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 1013 - 1018. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Marra, L. Hillejan, G. Zaboura, T. Fujimoto, D. Greschuchna, and G. Stamatis Pathologic N1 non-small cell lung cancer: Correlation between pattern of lymphatic spread and prognosis J. Thorac. Cardiovasc. Surg., March 1, 2003; 125(3): 543 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, E. A. Rendina, T. De Giacomo, E. Mercadante, F. Francioni, F. Pugliese, M. Moretti, and G. F. Coloni Nd:YAG laser resection of lung cancer invading the airway as a bridge to surgery and palliative treatment Ann. Thorac. Surg., October 1, 2002; 74(4): 995 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Vaporciyan, K. W. Merriman, F. Ece, J. A. Roth, W. R. Smythe, S. G. Swisher, G. L. Walsh, J. C. Nesbitt, and J. B. Putnam Jr Incidence of major pulmonary morbidity after pneumonectomy: association with timing of smoking cessation Ann. Thorac. Surg., February 1, 2002; 73(2): 420 - 426. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Venuta, E. A. Rendina, T. De Giacomo, E. Mercadante, A. M. Ciccone, M. T. Aratari, M. Moretti, and G. F. Coloni Endoscopic treatment of lung cancer invading the airway before induction chemotherapy and surgical resection Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 464 - 467. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.J. Poncelet, M. Lonneux, E. Coche, B. Weynand, and Ph. Noirhomme PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma Eur. J. Cardiothorac. Surg., September 1, 2001; 20(3): 468 - 475. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bernard, O. Bouchot, O. Hagry, and J. P. Favre Risk analysis and long-term survival in patients undergoing resection of T4 lung cancer Eur. J. Cardiothorac. Surg., August 1, 2001; 20(2): 344 - 349. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Fujimoto, G. Zaboura, S. Fechner, L. Hillejan, T. Schroder, A. Marra, T. Krbek, M. Hinterthaner, D. Greschuchna, and G. Stamatis Completion pneumonectomy: Current indications, complications, and results J. Thorac. Cardiovasc. Surg., March 1, 2001; 121(3): 484 - 490. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |